Risks

Brazilian medical-education demand remains tied to household affordability and financing conditions, but AFYA’s domestic scale and brand breadth should cushion enrollment volatility better than smaller peers.

Regulatory scrutiny on tuition caps, program approvals, and physician-training policy can compress pricing and growth, yet AFYA’s diversified campus and digital mix is less exposed than single-format peers.

Interest-rate sensitivity still affects student credit demand and debt service, but AFYA’s current liquidity and moderate leverage reduce refinancing pressure versus more levered education operators.

Competition for high-quality applicants and clinical placements can pressure conversion and retention, although AFYA’s established regional footprint and physician-network relationships provide stronger positioning than newer entrants.

Opportunities

Brazil’s structural shortage of physicians supports multi-year enrollment demand, and AFYA is better positioned than smaller peers to capture that growth through scale and recognized medical-school brands.

The company’s digital and hybrid offerings can expand addressable demand and improve student acquisition efficiency, giving AFYA a broader monetization path than campus-only competitors.

Stable liquidity and manageable leverage support continued investment in capacity and student support, which should help AFYA defend share while less flexible peers face tighter capital constraints.

High cash conversion and solid current liquidity provide resilience to absorb cyclical demand swings, allowing AFYA to sustain growth initiatives more consistently than financially constrained peers.

Overall Score

AFYA’s forward positioning is supported by durable physician-demand growth and scale advantages, while regulatory and affordability risks remain meaningful but appear more manageable than for smaller peers.